-1.54%
Today
Loading 1D prices…
Company profile
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Sector
Health Care
Industry
Ophthalmic Goods
Exchange
Nasdaq
Display currency
USD
Location
San Ramon, CA, United States
Employees
15K
Fiscal year end
1031
CIK
711404
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| BLCOBausch + Lomb Corporation Common Shares | $6B | $5.1B | -7.06% | -$1.02 | -1.79% | Hold |
| ALCAlcon Inc. Ordinary Shares | $31.5B | $10.4B | +9.42% | $1.98 | -1.69% | Buy |
| WRBYWarby Parker Inc. Class A Common Stock | $3B | $871.9M | +0.19% | $0.01 | -0.85% | Buy |
| EYENational Vision Holdings Inc. Common Stock | $1.3B | $2B | +1.49% | $0.37 | +2.55% | Buy |
| STAASTAAR Surgical Company Common Stock | $1.1B | $239.4M | -33.60% | -$1.62 | -8.12% | Hold |